1. Introduction {#sec1}
===============

Chronic pain (CP) is a worldwide public health problem that causes a substantial burden on healthcare systems and society, taking into account its high prevalence, economic costs, and the quality of life impairment of the patients and their families. CP requires a multidisciplinary approach for its adequate assessment and management \[[@B1]--[@B5]\]. For more than twenty years, the International Association for the Study of Pain (IASP) defined chronic CP as "pain that persists beyond normal tissue healing time, which is assumed to be 3 months" \[[@B6]\]. Variations in the definition of CP between and within countries, differences in standards of living and healthcare resources, high prevalence of pain-generating diseases, cultural background, and local traditions can help explain the estimated CP prevalence ranging from 11% to 55% \[[@B2], [@B7]--[@B9]\]. In a recent epidemiological study, CP prevalence in Portugal was estimated at 37% \[[@B10]\]. CP of moderate to severe intensity has been estimated to occur in 19% of European adults and 40% of them reported inadequate management of their pain \[[@B8], [@B11]\].

CP is one of the most common reasons why people seek medical care \[[@B1]\]. The economic impact of CP in the USA, in 2008, ranged from \$560 to \$635 billion USD \[[@B12]\]; in Portugal, it was €4611.69 million (in 2010), corresponding to 2.71% of the Portuguese annual gross domestic product, with 42.7% direct and 57.3% indirect costs \[[@B2]\]. Indirect costs of CP are mainly linked to work absenteeism with reduced levels of productivity and increased risk of leaving the labor market \[[@B13]\].

Ideally, supported by the most recent guidelines for the CP management, these patients should have access to a multidisciplinary range of diagnostic and therapeutic modalities appropriate to their clinical condition \[[@B14]--[@B17]\]. The primary emphasis should be placed on pain management to improve physical and social function and minimize the disability \[[@B18]--[@B20]\]. Pain management includes pharmacological therapy, psychological assessment and treatment, invasive techniques, occupational therapy, and rehabilitation medicine \[[@B2], [@B15], [@B20]--[@B25]\]. Interventional Pain Management (IPM) encompasses a wide variety of techniques such as epidural injections \[[@B26]--[@B29]\], nerve blocks \[[@B18], [@B21], [@B30]\], joint infiltrations \[[@B31], [@B32]\], spinal cord stimulation \[[@B33], [@B34]\], botulinum toxin application \[[@B35]--[@B37]\], and radiofrequency denervation \[[@B38], [@B39]\]. Recent data suggests that some of the IPM techniques allow a superior improvement in physical and functional status of CP patients \[[@B18], [@B25], [@B26], [@B35], [@B38]\], as well as a reduction in associated work absenteeism \[[@B18]\]. Other therapeutic procedures (OTP) are also performed on-site at multidisciplinary chronic pain clinics (MCPC), namely, acupuncture \[[@B40]--[@B46]\] and infusion of parenteral drugs \[[@B47]--[@B49]\].

In Portugal, there is no available information regarding patterns of prescription of IPM or OTP performed on-site at MCPC. Therefore, as a part of a larger real-world outcomes research prospective cohort study on CP patients followed at MCPC, this study inquired about the utilization of those techniques and procedures. We aimed at describing quantitatively and qualitatively the patterns of prescription of IPM and OTP performed on-site at MCPC in Portugal.

2. Methods {#sec2}
==========

2.1. Selection and Description of Participants {#sec2.1}
----------------------------------------------

Participants were recruited at their first consultation in four MCPC from the North of Portugal, in the context of a large real-world outcomes research project. The eligible population included adult patients (≥18 years old) with chronic noncancer pain lasting more than 3 months (the standard IASP criteria for CP \[[@B50]\]) or with cancer pain regardless of its duration. Patients with psychiatric and/or cognitive impairment, unable to communicate verbally or not fluent in Portuguese were excluded. Participants were followed for twelve months and their clinical records were obtained at baseline and six and 12 months. From all 1343 patients eligible, 808 patients were elected to be part of this study. From these, 139 patients had IPM at least once during the one-year follow-up (Supplement 1 in Supplementary Material available online at <https://doi.org/10.1155/2017/8402413>).

All participating patients were previously informed of the study objectives and about the data selection and collection procedures, and questions regarding the study, posed by the patients, were properly answered by the research team. All participating patients signed an informed consent form. The study protocol was approved by institutional review boards, ethics committees of the participating hospitals, and CNPD, the Portuguese Data Protection Authority.

2.2. Instruments and Variables {#sec2.2}
------------------------------

A structured questionnaire was used in baseline interviews. For the purpose of the present study the following data were systematically collected: demographic characteristics, clinical and pain characteristics, and IPM and OTP performed on-site at MCPC prescribed. The Brief Pain Inventory (BPI) \[[@B51]\] which is recommended by consensus groups in the area of measurement and evaluation of pain \[[@B52]\] was used. This instrument was constructed for measuring and evaluating pain in a multidimensional perspective. It includes 15 items evaluating pain presence, severity, location, functional interference, therapeutic strategies, and efficacy of pain management. It is easily applicable, fast, and simple and with very good psychometric properties \[[@B53]--[@B56]\]. For the present study, only two constructs were assessed: pain severity and functional interference. Pain severity scale entails four items, maximum, minimum, on average, and at this moment, rated with a numerical scale (0 \[no pain\] to 10 \[the worst pain\]) and categorized using Serlin et al. classification \[[@B57]\]. The functional interference scale consists of seven items with numerical rating scale (0 \[no interference\] to 10 \[extreme interference\]) that assess pain interference in general activities, mood, mobility, work, personal relationships, sleep, and pleasure to live.

In the descriptive analysis of the sample (all patients) and subsamples (patients with and without IPM), we defined the general characteristics, including sociodemographic (sex, age, educational level, and family support), professional/occupational status, pain characteristics (duration, persistence pattern, location, severity, and interference), general health, and clinical variables (International Statistical Classification of Diseases and Related Health Problems- (ICD-) 10 diagnostic classification). The persistence pattern of pain was classified as continuous, pain present every day/always, or discontinuous (recurrent \[pain present once to several times/week\] and sporadic \[pain present less than once to several times/month\]).

2.3. Statistical Analysis {#sec2.3}
-------------------------

Categorical variables were described as absolute (*n*) and relative (%) frequencies; continuous variables were described using the median and interquartile ranges considering the tested asymmetric (not normal) distribution or mean and standard deviation otherwise. We used the Chi-square test, or the Fisher\'s exact test, to test hypotheses for categorical variables. In the case of continuous variables (with asymmetrical distribution) the Mann--Whitney test was used. For all hypothesis tests a significance level of *α* = 0.05 was considered. The statistical analysis was performed using the software SPSS v21.0®.

3. Results {#sec3}
==========

[Table 1](#tab1){ref-type="table"} shows the number of patients that were prescribed IPM and/or OTP throughout the study. Considering IPM, nerve blocks were the most frequently prescribed at all time points (39 patients at baseline, 32 patients at 6 months, 20 patients at 12 months, and 88 patients in total throughout the one-year follow-up). On the contrary, botulinum toxin and viscosupplementation were prescribed to a few patients and almost exclusively at baseline. Neuromodulation by neurostimulation was only prescribed to one patient at 6 months. OTP were also prescribed to a considerable number of patients. Among them, acupuncture was prescribed to 52 patients throughout the study, followed by drug infusions to 31 patients.

Sociodemographic characteristics of all patients, patients with IPM, and patients without IPM are described in [Table 2](#tab2){ref-type="table"}. It was observed that 17.2% of the patients followed in MCPC had IPM prescribed, of which 71.9% were women and 28.1% men. Moreover, age was significantly lower in patients with IPM (54.6 (44.0--65.0) versus 59.7 (50.0--71.0) years, *p* \< 0.001). Elderly patients (over 75 years) were less frequently prescribed IPM. Patients with IPM were mainly full- or part-time workers while those without IPM were mostly retirees (*p* \< 0.001).

[Table 3](#tab3){ref-type="table"} shows pain clinical characteristics, at the inclusion time in our study, among all patients, patients with IPM, and patients without IPM. Almost 1/3 of the patients with IPM had pain for over 10 years, while almost 90% of patients with pain duration from 3 to 12 months did not have IPM (*p* = 0.006). Patients in both groups referred to almost exclusively continuous pain. Significant differences in pain intensity could only be seen for pain at its worst (8.01 without IPM versus 7.23 with IPM; *p* = 0.003). The location of the pain was heterogeneous and statistically significant differences were found; in all patients that indicated pain in unspecified bones, joints, and muscles 92.1% were patients without IPM, whereas among all cases of pain in inguinal and pelvic region 31.2% are reported by patients with IPM (*p* = 0.047). Patients with IPM had significantly lower pain interference score (*p* \< 0001). Specifically, pain-related interference was inferior in general ability (6.20 ± 3.26 versus 7.04 ± 2.71, *p* = 0.015), walking ability (5.76 ± 3.81 versus 6.67 ± 3.44, *p* = 0.024), normal work (6.09 ± 3.53 versus 7.26 ± 2.82, *p* \< 0.001), relations with other people (3.17 ± 3.64 versus 4.22 ± 3.58, *p* = 0.002), and enjoyment of life (4.18 ± 3.95 versus 5.55 ± 3.79, *p* \< 0.001). More than 57% of patients who had no pain interference had invasive techniques for pain management, while 88.1% of patients with severe interference did not had IPM prescribed. In general health no differences were found.

Using the ICD 10 to classify patient\'s pathologies, 34 diagnoses were obtained from all patients. The five most prevalent diagnoses in patients with IPM were low back pain (28 patients), chronic postoperative pain (16 patients), knee pain (16 patients), pelvic and perineal pain (13 patients), and low back with sciatica (11 patients). We only found five significant differences between patients with and without IPM in what concerns the diagnosis. IPM was only used in 2.8% of patients with fibromyalgia (*p* = 0.013) and 4.2% of patients with cancer pain (*p* \< 0.001), while it was used in 36.7% of patients with low back pain with sciatica (*p* = 0.011), 41% of patients with knee (*p* \< 0.001) pain, and 46.4% of patients with pelvic or perineal pain (*p* \< 0.001) (Supplement 2).

Throughout the study 420 treatments were prescribed as seen in [Table 4](#tab4){ref-type="table"}. The most prescribed IPM in all assessment time points was nerve blocks. In one-year follow-up nerve blocks were 108 times prescribed followed by radiofrequency (31 prescriptions) and viscosupplementation (22 prescriptions). The botulinum toxin and viscosupplementation prescriptions were scarce and occurred almost exclusively at baseline. The most prescribed OTP performed on-site at MCPC at baseline were infusions (43 prescriptions) and at 6 and 12 months acupuncture (73 and 45 prescriptions, resp.).

The five most frequent diagnoses of patients that were prescribed each of the IPM and/or OTP are shown in [Table 5](#tab5){ref-type="table"}. IPM was not exclusive to patients with a specific diagnosis. Nerve blocks, epidural, and radiofrequency were extensively used in several diagnoses, and the same occurred with acupuncture. Botulin toxin was prescribed to 69.2% of patients with pelvic and perineal pain; viscosupplementation was prescribed to 68.4% of patients diagnosed with knee pain. Considering OTP performed on-site at MCPC, drug infusions were prescribed to 57.9% of patients with cancer pain.

There was large heterogeneity in the type of treatments and prescription frequency in each MCPC. It is noted that there are techniques only prescribed in some MCPC, such as viscosupplementation, radiofrequency, botulinum toxin, and neurostimulation. One MCPC had only OTP performed on-site (Supplement 3).

4. Discussion {#sec4}
=============

There are very few studies focused on IPM utilization patterns in multidisciplinary CP clinics \[[@B17], [@B24]\]. To our best knowledge, this is the first study focused on this issue in Portugal and one of the very few elsewhere.

We found that nerve blocks were the most frequent IPM prescribed in MCPC; with a total of 420 IPM or OTP prescribed during the one-year follow-up. A total of 139 patients (17.2%) in our cohort received IPM for their CP management. Of those, almost 32.4% had pain for over 10 years and 92.1% of these reported a continuous pain pattern. There was a diversity of IPM prescribed in the participating MCPC, and botulinum toxin, viscosupplementation, neurostimulation, and radiofrequency were only available in very few centers. In our cohort there is a higher prevalence of women with CP which is in accordance with the available literature \[[@B10], [@B20], [@B58]\], and average pain intensity was approximately 6 in a 0--10 numerical rating scale.

In general, the success of these techniques is partly dependent on the experience and skill of the provider. There is controversy over the evidence that supports these techniques \[[@B16]\], as there is no sufficient data to ascertain the efficacy of some procedures. In some cases, pain relief is only observed during a short period and does not essentially convert into improved function and reduced work absenteeism \[[@B59]\]. Moreover, there is a risk of potential complications associated, but most are transient and often subclinical \[[@B30]\]. IPM techniques have been used for a long time as a last option for patients when all other conservative approaches have failed. Therefore, it is understandable that patients to whom they are actuality prescribed have a much longer reported pain duration \[[@B59]\].

In the present study, IPM were prescribed mainly to patients that did not report significant interference of pain, as measured by the functional interference scale of the Brief Pain Inventory, while the vast majority of patients that reported severe interference were not prescribed IPM. The reasons for these unexpected results are not clear at present, and one can only speculate that patients with severe interference suffered from conditions and/or had a health status (e.g., comorbidities) less likely to be treated by IPM, but additional data is required to investigate this issue.

Among the great variety of IPM used in multidisciplinary pain management \[[@B14], [@B25]\], six techniques plus three OTP performed on-site at MCPC were prescribed in the course of our study.

Nerve blocks, the most frequently prescribed technique in the present study (88 patients), consist in anesthetics delivered to visceral and peripheral nerves in order to interrupt nociceptive input at the source of pain \[[@B16], [@B28]\]. This procedure may be understood, especially by patients, as curative, but similarly to other IPM techniques, that is not the case. However, it can be very useful, for instance, to alleviate pain and allow patient to take part in their physical therapy \[[@B30]\].

Viscosupplementation consists of intra-articular injection of hyaluronic acid derivatives. It is one of the more used local treatments for osteoarthritis along with corticosteroid injection. It has been used mainly in knee joint, where it shows moderate and significant pain reduction and increased function \[[@B32]\], but a recent meta-analysis provided no evidence that the effect remains longer than six months \[[@B31]\].

Radiofrequency denervation consists in nerve ablation using heat generated by a radiofrequency current \[[@B38]\]. Facet joints radiofrequency is one of the most prevalent indications for its use with high rates of clinical improvement. However, these effects have also a limited temporal efficacy \[[@B25], [@B39]\].

Botulinum toxin injections as well as acupuncture and dry needling techniques are effective options for myofascial pain, namely, trigger point\'s deactivation \[[@B36], [@B38]\]. However there is no clear evidence about long-term effectiveness of botulinum toxin treatment \[[@B35]\].

Epidural injection was primarily recommended for radicular pain from a herniated disc but could also be performed in patients with spinal stenosis and other low back pain conditions \[[@B25], [@B26]\]. Fair evidence of moderate benefit versus placebo injection for short-term low back pain relief was found \[[@B27]\], and even when compared with other pharmacological treatment, epidural injection may be better in some outcomes, but the differences are transient and modest \[[@B28]\]. In fact, epidural steroid injections are the most commonly performed procedure in USA, differing from what we have found in our study, yet evidence is controversial and inconclusive as to their long-term effectiveness \[[@B25], [@B28], [@B29]\]. The potential complications associated with neuraxial techniques performance may explain the low prevalence reported on its use.

Neuromodulation is used in some Portuguese MCPC. However, during the recruitment period of our study there was only one patient who was referred to this treatment \[[@B33]\]. Spinal cord stimulation has formal indication in CP conditions such as failed back surgery, complex regional pain syndrome, peripheral vascular diseases (Buerger disease, Raynaud syndrome, and limb ischemia I/II), and refractory*angina pectoris* \[[@B34]\].

Taking into consideration OTP performed on-site, prescribed in the MCPC, acupuncture was the most frequently prescribed. Some evidence supports acupuncture effectiveness for chronic low back pain treatment \[[@B41]\], fibromyalgia \[[@B42]\], and neck pain treatment \[[@B43]\]. It is increasingly prescribed \[[@B40]\], but the lack of strong studies that clearly prove its effectiveness has delayed its global recognition \[[@B44]--[@B46]\].

Pain is a common symptom in cancer patients. In spite of advances in pain management, effective pain control remains an ongoing challenge, despite high doses of opioids \[[@B47]\]. Drugs infusions can be used safely and should be considered to manage cancer neuropathic pain \[[@B47], [@B48]\]. Trigeminal neuralgia is the most common neuralgia in which intravenous infusion of lidocaine may be a therapeutic option when other treatments are ineffective \[[@B49]\]. Thus further investigation will be needed to evaluate clinical significance of infusion therapy \[[@B48]\].

The present findings clarify which and in what extent IPM and OTP performed on-site at MCPC are being prescribed. This study has several strengths, namely, inclusion of several MCPC, a well-structured and detailed questionnaire, telephonic interviews performed systematically, a restricted and trained team, a large sample, and a 12-month follow-up period. The data presented are unique and to the best of our knowledge there are no similar data in other MCPC that describe their current clinical practice and are useful for comparison and benchmarking.

We have a comprehensive and systematic description of IPM and OTP performed on-site, prescribed, and actually used in MCPC, constituting the clear added value of our study. However, some IPM can be performed for therapeutic or diagnostic purposes and this has not been differentiated in the present study. Further ongoing research will provide data on the evaluation of real-world effectiveness and patient\'s reported satisfaction by type and timing of techniques performed.

5. Conclusions {#sec5}
==============

In Portugal IPM is available in most MCPC, but with marked diversity in the types of techniques and clinical indications. IPM is still seldom prescribed, with only 17.2% of patients having IPM as part of their management. Future studies focused on patient\'s reported effectiveness and satisfaction are needed.
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###### 

Number of patients that received a prescription of interventional pain management and other therapeutic procedures performed on-site at multidisciplinary chronic pain clinics.

  ---------------------------------------------------------------------------------------------------------------------------------------------------
                                     Baseline\     Six months\   Twelve months\   Total throughout the one-year follow-up\                     
                                     (*n* = 808)   (*n* = 801)   (*n* = 744)      (*n* = 744)                                                  
  ---------------------------------- ------------- ------------- ---------------- ------------------------------------------ ----- ----- ----- ------
  IPM and/or OTC performed on-site                                                                                                             

   Yes                               89            122           139              ---                                                          

   No                                719           679           605              ---                                                          

                                                                                                                                               

                                     *n*           \%            *n*              \%                                         *n*   \%    *n*   \%

                                                                                                                                               

  IPM                                                                                                                                           

   Nerve blocks                      39            4.8           32               4.0                                        20    2.7   88    11.8

   Viscosupplementation              18            2.2           1                0.1                                        1     0.1   16    2.2

   Radiofrequency                    13            1.6           11               1.4                                        5     0.7   28    3.8

   Botulinum toxin                   10            1.2           2                0.2                                        1     0.1   12    1.6

   Epidural injections               9             1.1           9                1.1                                        1     0.1   17    2.3

   Neurostimulation                  ---           ---           1                0.1                                        ---   ---   1     0.1

   Total                             89            11.0          56               7.0                                        28    3.8   162   21.8

  OTP performed on-site                                                                                                                         

   Acupuncture                       33            4.1           20               2.5                                        12    1.6   52    7.0

   Infusions                         21            2.6           8                1.0                                        11    1.5   31    4.2

   Mesotherapy                       1             0.1           1                0.1                                        ---   ---   2     0.3

   Total                             55            6.8           29               3.6                                        23    3.1   85    11.4
  ---------------------------------------------------------------------------------------------------------------------------------------------------

At the top of the table, in each row there is the cumulative number of patients who had interventional pain management and/or other therapeutic procedures prescribed at multidisciplinary chronic pain clinics at each assessment time point. *n*, number of patients at each assessment time point. Furthermore, in each row there are the number of patients (*n*) and proportions of patients (%) that were prescribed interventional pain management or other therapeutic procedures performed on-site at multidisciplinary chronic pain clinics at each assessment time point and during the follow-up time. IPM, interventional pain management. OTP, other therapeutic procedures.

###### 

Sociodemographic characteristics of all patients, chronic pain patients with interventional pain management, and chronic pain patients without interventional pain management.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                     All ^†^CP patients   CP patients without IPM   CP patients with IPM   ^*∗*^ *p*                          
  -------------------------------------------------- -------------------- ------------------------- ---------------------- ------------- ----- ------- ------ -------------
  Gender                                                                                                                                                       

   Male                                              265                  32.8                      226                    33.8          39    28.1    14.7   0.199

   Female                                            543                  67.2                      443                    66.2          100   71.9    18.4   

   Total                                             808                  100.0                     669                    100.0         139   100.0   17.2    

                                                                                                                                                              

  Age                                                                                                                                                          

   Median\                                           60.0\                59.7\                     54.6\                  **\<0.001**                        
   (P25--P75)                                        (48.3--70.8)         (50.0--71.0)              (44.0--65.0)                                              

                                                                                                                                                              

  Age categories                                                                                                                                               

   18--24 years                                      9                    1.1                       5                      0.7           4     2.9     44.4   **0.010**

   25--34 years                                      31                   3.8                       21                     3.1           10    7.2     32.3   

   35--44 years                                      108                  13.4                      87                     13.0          21    15.1    19.4   

   45--54 years                                      164                  20.3                      132                    19.7          32    23.0    19.5   

   55--64 years                                      190                  23.5                      156                    23.3          34    24.5    17.9   

   65--74 years                                      180                  22.3                      154                    23.0          26    18.7    14.4   

   75 years or older                                 126                  15.6                      114                    17.0          12    18.6    9.5    

   Total                                             808                  100.0                     669                    100.0         139   100.0   17.2    

                                                                                                                                                              

  Family household                                                                                                                                             

   Alone                                             84                   10.4                      69                     10.3          15    10.8    17.9   0.121

   With wife/husband or partner                      317                  39.2                      262                    39.2          55    39.6    17.4   

   With wife/husband or partner and sons/daughters   244                  30.2                      192                    28.7          52    37.4    21.3   

   With sons/daughters                               62                   7.7                       54                     8.1           8     5.8     12.9   

   In elderly care homes                             2                    0.2                       2                      0.3           ---   ---     ---    

   Other                                             99                   12.3                      90                     13.5          9     6.5     9.1    

   Total                                             808                  100.0                     669                    100.0         139   100.0   17.2    

                                                                                                                                                              

  Professional/occupational status                                                                                                                            

   Full or part-time worker                          242                  30.0                      180                    26.9          62    44.6    25.6   \<**0.001**

   Student                                           6                    0.7                       5                      0.7           1     0.7     16.7   

   Unemployed                                        101                  12.5                      84                     12.6          17    12.2    16.8   

   House worker or domestic worker                   33                   4.1                       26                     3.9           7     5.0     21.2   

   Retired or preretired                             387                  47.9                      342                    51.1          45    32.0    11.6   

   Other                                             39                   4.8                       32                     4.8           7     5.0     17.9   

   Total                                             808                  100.0                     669                    100.0         139   100.0   17.2    

                                                                                                                                                              

  Education level                                                                                                                                              

   No education                                      24                   3.0                       24                     4.1           ---   ---     ---    0.195

   1--4 years (basic 1st cycle)                      401                  49.8                      330                    56.4          71    51.1    17.7   

   5--9 years (basic 2nd and 3rd cycles)             189                  23.4                      156                    26.7          33    23.7    17.5   

   10--12 years (secondary)                          85                   10.5                      66                     11.3          19    13.7    22.4   

   More than 12 years (higher)                       86                   10.7                      74                     12.6          12    8.6     14.0   

   Other                                             21                   2.6                       17                     2.6           4     2.9     19.0   

   Total                                             806                  100.0                     667                    100.0         139   100.0   17.2    
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Each row of the table includes absolute (*n*) and relative (%) frequencies of each characteristic and the utilization frequency (%) of interventional pain management by category (UF). Highlighted in bold are statistically significant results, at a 0.05 significance level. CP, chronic pain. IPM, interventional pain management. P25--P75, 25th percentile and 75th percentile (representing the interquartile range).^*∗*^*p* value for statistical hypothesis tests comparing the subsample of CP subjects with IPM to CP subjects without IPM. Chi-square test or Fisher\'s exact test for categorical variables and Mann--Whitney test for numerical variables were used. ^†^Chronic pain was defined, using the IASP standard definition, as pain present with duration ≥3 months.

###### 

Clinical characteristics of all patients, chronic pain patients with interventional pain management, and chronic pain patients without interventional pain management.

  Clinical characteristics of pain          All ^†^CP patients   CP patients without IPM   CP patients with IPM   ^*∗*^ *p*                            
  ----------------------------------------- -------------------- ------------------------- ---------------------- ----------- ------ -------- -------- -------------
                                            *n*                  \%                        *n*                    \%          *n*    \%       UF (%)    
                                                                                                                                                       
  Duration (categorized)                                                                                                                                
   ≤3 months--≤1 year                       218                  27.3                      196                    29.7        22     15.8     10.1     **0.006**
   \<1-≤2 years                             110                  13.8                      87                     13.2        23     16.5     20.9     
   \<2--≤5 years                            157                  19.6                      128                    19.4        29     20.9     18.5     
   \<5--≤10 years                           123                  15.4                      103                    15.6        20     14.4     16.3     
   \>10 years                               191                  23.9                      146                    22.1        45     32.4     23.6     
   Total                                    799                  100.0                     660                    100.0       139    100.0    17.4      
                                                                                                                                                       
  ^‡^Persistence pattern                                                                                                                                
   Continuous                               754                  93.4                      626                    93.7        128    92.1     17.0     0.455
   Discontinuous                            53                   6.6                       42                     6.3         11     7.9      20.8     
   Total                                    807                  100.0                     668                    100.0       139    100.0    17.2      
                                                                                                                                                       
                                            Mean (SD)            Mean (SD)                 Mean (SD)                                                   
                                                                                                                                                       
  Intensity                                                                                                                                            
   Pain on average (0--10 NRS)              5.96                 (2.13)                    6.00                   (2.01)      5.77   (2.50)            0.641
   Pain at its least (0--10 NRS)            3.63                 (2.50)                    3.63                   (2.44)      3.63   (2.79)            0.759
   Pain at its worst (0--10 NRS)            7.88                 (2.11)                    8.01                   (1.98)      7.23   (2.61)            **0.003**
   Pain right now (0--10 NRS)               4.83                 (2.99)                    4.88                   (2.94)      4.58   (3.23)            0.304
                                                                                                                                                       
                                            *n*                  \%                        *n*                    \%          *n*    \%       UF (%)    
                                                                                                                                                       
   No pain                                  14                   1.8                       6                      0.9         8      6.2      57.1     \<**0.001**
   ^§^Mild                                  229                  29.4                      181                    27.8        48     37.2     21.0     
   ^§^Moderate                              244                  31.3                      215                    33.0        29     22.5     11.9     
   ^§^Severe                                293                  37.6                      249                    38.2        44     34.1     15.0     
   Total                                    780                  100.0                     651                    100.0       129    100.0    16.5      
                                                                                                                                                       
  ^\|\|^Location                                                                                                                                        
   Lower limb                               742                  34.4                      590                    33.7        152    38.7     20.5      
   Dorsum and lower back                    414                  19.3                      343                    19.6        71     18.1     17.1      
   Upper limb                               363                  16.9                      288                    16.4        75     19.1     20.7      
   Cervical and facial region               261                  12.1                      224                    12.8        37     9.4      14.2     **0.047**
   Bones/joints/muscles- unspecified        89                   4.1                       82                     4.7         7      2.3      7.9       
   Abdominal and anterior thoracic region   87                   4.0                       78                     4.4         9      6.1      10.3      
   Inguinal and pelvic region               77                   3.6                       53                     3.0         24     4.6      31.2      
   Other                                    115                  5.6                       97                     5.5         18     4.6      15.7      
   Total                                    2150                 100.0                     1757                   100.2       393    100.0    18.3      
                                                                                                                                                       
                                            Mean (SD)            Mean (SD)                 Mean (SD)                                                   
                                                                                                                                                       
  Pain-related interference                                                                                                                            
   General activity                         6.90                 (2.82)                    7.04                   (2.71)      6.20   (3.26)            **0.015**
   Mood                                     6.25                 (3.28)                    6.37                   (3.21)      5.64   (3.58)            0.054
   Walking ability                          6.52                 (3.51)                    6.67                   (3.44)      5.76   (3.81)            **0.024**
   ^¶^Normal work                           7.06                 (2.98)                    7.26                   (2.82)      6.09   (3.53)            **\<0.001**
   Relations with other people              4.05                 (3.60)                    4.22                   (3.58)      3.17   (3.64)            **0.002**
   Sleep                                    5.64                 (3.80)                    5.72                   (3.81)      5.20   (3.74)            0.087
   Enjoyment of life                        5.33                 (3.84)                    5.55                   (3.79)      4.18   (3.95)            **\<0.001**
                                                                                                                                                       
                                            *n*                  \%                        *n*                    \%          *n*    \%       UF (%)    
                                                                                                                                                       
  ^£^Interference                                                                                                                                       
   No interference                          14                   1.8                       6                      0.9         8      6.3      57.1     \<**0.001**
   Mild                                     229                  29.4                      180                    27.6        49     38.3     21.4     
   Moderate                                 244                  31.3                      208                    31.9        36     28.1     14.8     
   Severe                                   293                  37.6                      258                    39.6        35     27.3     11.9     
   Total                                    780                  100.0                     652                    100.0       128    100.0    16.4      
                                                                                                                                                       
  General health                                                                                                                                        
   Excellent                                13                   1.6                       11                     1.7         2      1.4      15.4      
   Very good                                15                   1.9                       12                     1.8         3      2.2      20.0      
   Good                                     117                  14.6                      94                     14.1        23     16.5     19.7     0.082
   Fair                                     342                  42.5                      271                    40.8        71     51.1     20.8      
   Poor                                     317                  39.4                      277                    41.7        40     28.8     12.6      
   Total                                    804                  100.0                     665                    100.0       139    100.0    17.3      

Each row of the table includes the absolute (*n*) and relative (%) frequencies of each characteristic, the utilization frequency (%) of interventional pain management by category (UF (%)), and in some cases the mean and standard deviation (SD). Highlighted in bold are statistically significant results, at a 0.05 significance level. CP, chronic pain. IPM, interventional pain management. SD, standard deviation. ^*∗*^*p* value for statistical hypothesis tests comparing the subsample of CP subjects with IPM to CP subjects without IPM. Chi-square test or Fisher\'s exact test for categorical variables and Mann--Whitney test for numerical variables were used. ^†^Chronic pain was defined, using the IASP standard definition, as pain present with duration ≥3 months. ^‡^Persistence pattern: continuous---pain present every day/ always; discontinuous---recurrent (pain present once to several times/ week); and sporadic (pain present less than once to several times/month). ^§^Pain intensity score was categorized taking into account the Serling classification: mild (1--4), moderate (5-6), and severe pain intensity (7--10). ^\|\|^Multiple pain locations were recorded for each patient. ^¶^Including both work outside the home and housework. ^£^Pain interference was categorized as mild (1--4), moderate (5-6), and severe pain interference (7--10).

###### 

Prescriptions and rate of prescription of interventional pain management and other therapeutic procedures performed on-site at multidisciplinary chronic pain clinics at baseline, six months, and twelve months and during the whole follow-up period.

  ---------------------------------------------------------------------------------------------------------------------------------------------------
                                   Baseline\      Six months\    Twelve months\   Total throughout the one-year follow-up\                     
                                   (*nt* = 808)   (*nt* = 801)   (*nt* = 744)     (*nt* = 744)                                                 
  -------------------------------- -------------- -------------- ---------------- ------------------------------------------ ----- ----- ----- ------
  Interventional pain management                                                                                                                

   Nerve blocks                    41             5.1            51               6.4                                        37    5.0   108   14.5

   Viscosupplementation            19             2.4            6                0.7                                        4     0.5   22    3.0

   Radiofrequency                  12             1.5            16               2.0                                        5     0.7   31    4.2

   Botulinum toxin                 10             1.2            2                0.2                                        3     0.4   14    1.9

   Epidural injections             9              1.1            11               1.4                                        2     0.3   19    2.6

   Neurostimulation                ---            ---            1                0.1                                        ---   ---   1     0.1

   Total                           91             11.3           87               10.9                                       51    6.9   195   26.2

  OTP performed on-site                                                                                                                         

   Infusions                       43             5.3            38               4.7                                        25    3.4   95    12.8

   Acupuncture                     38             4.7            73               9.1                                        45    6.0   128   17.2

   Mesotherapy                     1              0.1            1                0.1                                        ---   ---   2     0.3

   Total                           82             10.1           199              14.0                                       70    9.4   225   30.2
  ---------------------------------------------------------------------------------------------------------------------------------------------------

Each row of the table includes the number of interventional pain management or other therapeutic procedures performed on-site at multidisciplinary chronic pain clinics at each assessment time point and during the follow-up time (*n*), the average number of prescriptions per 100 patients at each assessment time point (rate). *nt*, number of patients at each assessment time point. OTP, other therapeutic procedures.

###### 

Characterization of interventional pain management and other therapeutic procedures performed on-site at multidisciplinary chronic pain clinics by the five main diagnoses.

  *Interventional pain management*   *ICD-10 diagnostic classification*                                                                                                               
  ---------------------------------- ------------------------------------ ---------------------------------------------- ----------------------------- ------------------------------ ----------------------------------------------
  Nerve blocks                       Low back pain                        Chronic postoperative pain                     Low back pain with sciatica   Shoulder pain                  Cervicalgia
                                                                                                                                                                                      
   np (%)                            23 (25.7)                            14 (15.4)                                      9 (9.9)                       5 (5.5)                        5 (5.5)
   ni (%)                            32 (20.9)                            22 (14.4)                                      12 (7.8)                      7 (4.6)                        5 (3.3)
                                                                                                                                                                                      
  Viscosupplementation               Knee pain                            Unspecified osteoarthritis, unspecified site   Chronic postoperative pain    Pain in unspecified joint      Low back pain with sciatica
                                                                                                                                                                                      
   np (%)                            13 (68.4)                            3 (15.8)                                       1 (5.3)                       1 (5.3)                        1 (5.3)
   ni (%)                            22 (75.9)                            3 (10.3)                                       1 (3.4)                       2 (6.9)                        1 (3.4)
                                                                                                                                                                                      
  Botulinum toxin                    Pelvic and perineal pain             Central pain syndrome                          Chronic postprocedural pain   Cancer pain                    Lower abdominal pain, unspecified
                                                                                                                                                                                      
   np (%)                            9 (69.2)                             1 (7.7)                                        1 (7.7)                       1 (7.7)                        1 (7.7)
   ni (%)                            11 (73.3)                            1 (6.7)                                        1 (6.7)                       1 (6.7)                        1 (6.7)
                                                                                                                                                                                      
  Radiofrequency                     Low back pain                        Low back pain with sciatica                    Shoulder pain                 Knee pain                      Other hereditary and idiopathic neuropathies
                                                                                                                                                                                      
   np (%)                            7 (25.0)                             5 (17.9)                                       3 (10.7)                      3 (10.7)                       2 (7.1)
   ni (%)                            9 (27.3)                             5 (15.2)                                       3 (9.1)                       3 (9.1)                        2 (6.1)
                                                                                                                                                                                      
  Epidural injections                Low back pain                        Low back pain with sciatica                    Hip pain                      Chronic postoperative pain     Radiculopathy, lumbar region
                                                                                                                                                                                      
   np (%)                            5 (26.3)                             4 (21.1)                                       2 (10.5)                      2 (10.5)                       2 (10.5)
   ni (%)                            5 (22.7)                             4 (18.2)                                       2 (9.1)                       2 (9.1)                        3 (16.6)
                                                                                                                                                                                      
  Neurostimulation                   Chronic postoperative pain                                                                                                                        
                                                                                                                                                                                      
   np (%)                            1 (100.0)                                                                                                                                         
   ni (%)                            1 (100.0)                                                                                                                                         
                                                                                                                                                                                      
  *OTP performed on-site*            *ICD-10 diagnostic classification*                                                                                                               
                                                                                                                                                                                      
  Infusions                          Cancer pain                          Disorders of trigeminal nerve                  Chronic postoperative pain    Radiculopathy, lumbar region   Cervicalgia
                                                                                                                                                                                      
   np (%)                            22 (57.9)                            4 (10.5)                                       3 (7.9)                       2 (5.3)                        2 (5.3)
   ni (%)                            37 (45.1)                            26 (31.7)                                      5 (6.1)                       13 (15.9)                      13 (15.9)
                                                                                                                                                                                      
  Acupuncture                        Low back pain                        Cervicalgia                                    Myalgia                       Pain in unspecified joint      Fibromyalgia
                                                                                                                                                                                      
   np (%)                            15 (23.1)                            11 (16.9)                                      6 (9.2)                       5 (7.7)                        5 (7.7)
   ni (%)                            49 (30.4)                            12 (7.5)                                       27 (16.8)                     5 (3.1)                        22 (13.7)
                                                                                                                                                                                      
  Mesotherapy                        Low back pain                        Unspecified mononeuropathy of lower limb                                                                     
                                                                                                                                                                                      
   np (%)                            1 (50.0)                             1 (50.0)                                                                                                     
   ni (%)                            1 (50.0)                             1 (50.0)                                                                                                     

Each row of the table includes the number of patients and percentage (%) that were prescribed interventional treatments or other therapeutic procedures performed on-site at multidisciplinary chronic pain clinics (np) and the number and percentage (%) of prescribed interventional treatments or other therapeutic procedures performed on-site at multidisciplinary chronic pain clinics (ni). ICD, International Statistical Classification of Diseases and Related Health Problems. OTP, other therapeutic procedures.
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